Medpace Holdings, Inc.

MEDP

Medpace Holdings, Inc.

MEDP

Insider Sentiment (TTM):

Last Purchase:2025-02-27Last Sale:2026-05-28Shares Purchased (TTM):0Shares Sold (TTM):337,071

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:22,350,982Shares Outstanding:28,445,000Institutional Ownership Pct.:78.58%

Earnings Market Reaction:

Filing Date:2026-07-23Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Commercial Physical & Biological Research

IQV INCY CRL ABSI NRC OABI

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	503	653	497	285	46	441	669	657	511	407	245	95
Receivables Net Current	442	395	402	373	378	298	296	311	301	279	298	293
Prepaid Expense And Other Assets Current	106	92	90	79	97	82	63	64	61	59	50	61
Assets Current	1,050	1,139	990	737	521	821	1,029	1,033	873	745	594	449
Property Plant And Equipment Net	157	137	131	133	135	128	124	124	122	119	121	115
Operating Lease Right Of Use Asset	126	127	118	124	130	130	129	131	134	139	145	144
Goodwill	662	662	662	662	662	662	662	662	662	662	662	662
Intangible Assets Net Excluding Goodwill	33	33	33	34	34	34	34	35	35	35	36	36
Deferred Income Tax Assets Net	3	3	19	37	66	100	100	77	75	75	74	59
Other Assets Noncurrent	25	28	22	26	24	22	22	23	18	20	25	21
Assets	2,057	2,130	1,975	1,753	1,572	1,897	2,101	2,084	1,920	1,796	1,657	1,487
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	38	34	28	27	43	61	33	26	27	24	32	29
Accrued Liabilities Current	451	406	408	369	324	286	308	307	293	271	293	265
Contract With Customer Liability Current	905	856	854	834	809	719	711	671	638	617	560	519
Short Term Borrowings	-	-	-	-	-	-	-	-	-	-	0	0
Other Liabilities Current	42	48	53	54	45	56	54	37	35	45	40	36
Liabilities Current	1,435	1,345	1,344	1,284	1,220	1,122	1,105	1,041	993	957	925	849
Operating Lease Liability Noncurrent	120	122	114	119	125	127	126	128	132	136	142	143
Deferred Income Tax Liabilities Net	8	4	1	2	2	2	2	2	2	2	2	1
Other Liabilities Noncurrent	60	60	58	54	52	53	43	31	29	29	28	23
Liabilities	1,623	1,531	1,516	1,459	1,399	1,304	1,275	1,203	1,156	1,124	1,098	1,016
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Common Value	-12	-12	-12	-12	-12	-12	-12	-12	-12	-12	-12	-12
Additional Paid In Capital Common Stock	964	953	936	907	893	887	844	837	819	815	803	796
Retained Earnings Accumulated Deficit	-511	-336	-460	-596	-703	-270	8	66	-31	-119	-222	-300
Accumulated Other Comprehensive Income Loss Net Of…	-7	-7	-5	-6	-6	-12	-15	-9	-13	-12	-10	-13
Stockholders Equity	434	598	459	294	172	594	826	881	764	672	559	471
Liabilities And Stockholders Equity	2,057	2,130	1,975	1,753	1,572	1,897	2,101	2,084	1,920	1,796	1,657	1,487
Related Party	-	3	4	1	-1	3	4	7	1	2	2	-2
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	28	29	28	28	28	30	31	31	31	31	31	31
Shares Outstanding	28	29	28	28	28	30	31	31	31	31	31	31
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	5.55%	18.79%	36.81%	-	-	-	-	-	-	-	-	-
2025	8.28%	5.66%	14.60%	-4.16%	2.70%	4.92%	-1.09%	-6.49%	-0.27%	5.50%	11.72%	-6.39%
2024	-3.40%	-3.25%	8.81%	8.35%	-1.58%	-2.63%	-4.87%	5.94%	7.45%	1.51%	-12.43%	-6.94%
2023	-	-	-	-2.70%	9.11%	-6.82%	0.64%	10.04%	5.31%	11.41%	10.07%	7.82%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.73	0.85	0.74	0.57	0.43	0.73	0.93	0.99	0.88	0.78	0.64	0.53
Quick Ratio	0.66	0.78	0.67	0.51	0.35	0.66	0.87	0.93	0.82	0.72	0.59	0.46
Working Capital	-385.14M	-205.96M	-354.12M	-546.63M	-699.64M	-300.87M	-75.32M	-8.76M	-120.57M	-211.74M	-331.30M	-399.64M
Leverage & Debt
Debt to Equity	3.74	2.56	3.30	4.97	8.12	2.20	1.54	1.36	1.51	1.67	1.96	2.16
Interest Coverage TTM	38.03	49.23	41.86	29.93	20.80	16.69	17.88	21.57	33.07	47.71	80.66	103.18
Debt Ratio	0.79	0.72	0.77	0.83	0.89	0.69	0.61	0.58	0.60	0.63	0.66	0.68
Efficiency & Turnover
Asset Turnover TTM	1.53	1.33	1.24	1.23	1.28	1.17	1.12	1.16	1.22	1.23	1.25	1.27
Days Sales Outstanding TTM	53.77	47.21	50.38	52.97	55.53	48.86	51.47	53.25	51.80	49.92	53.40	55.51
Receivables Turnover TTM	6.79	7.73	7.24	6.89	6.57	7.47	7.09	6.85	7.05	7.31	6.84	6.58
Per Share Metrics
Diluted EPS TTM	17.21	15.90	15.28	15.03	14.35	13.35	12.63	11.40	10.59	9.77	8.88	8.60
Free Cash Flow Per Share TTM	25.08	25.00	23.64	24.05	20.27	17.80	18.49	17.25	16.22	15.35	12.91	12.33
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	20.97%	21.02%	21.14%	21.50%	21.40%	21.16%	21.19%	19.74%	18.79%	18.07%	17.86%	18.30%
Net Profit Margin TTM	17.67%	17.19%	17.83%	18.36%	18.74%	19.31%	19.17%	17.66%	16.74%	15.92%	15.00%	15.33%
Growth Metrics
Net Revenue Growth (1Y)	24.67%	24.19%	19.97%	13.88%	9.94%	9.87%	11.84%	16.24%	21.36%	25.57%	29.17%	29.62%
Net Income Growth (1Y)	17.50%	10.57%	11.56%	18.42%	23.11%	33.24%	42.99%	33.85%	26.48%	21.62%	15.26%	20.49%
EPS Growth (1Y)	19.28%	18.12%	19.72%	30.67%	33.39%	35.24%	41.90%	32.05%	24.63%	22.27%	21.51%	21.98%
Valuation Metrics
P/E TTM	30.36	29.67	35.91	33.41	21.46	22.24	25.43	28.34	37.56	39.89	33.30	27.15
P/B TTM	34.39	22.83	35.29	49.27	52.08	15.60	12.46	11.76	16.71	18.56	16.85	15.75
P/S TTM	5.36	5.10	6.40	6.13	4.02	4.29	4.88	5.00	6.29	6.35	4.99	4.16
Market Cap	14.92B	13.66B	16.20B	14.47B	8.98B	9.26B	10.28B	10.36B	12.76B	12.47B	9.42B	7.42B
Enterprise Value	14.42B	13.01B	15.70B	14.18B	8.93B	8.82B	9.62B	9.71B	12.25B	12.06B	9.35B	7.32B
Calculated Values
Free Cash Flow TTM	706.69M	711.00M	681.87M	676.77M	579.82M	540.93M	572.27M	535.65M	502.80M	473.34M	396.73M	377.76M
Net Debt	-502.69M	-652.68M	-497.05M	-285.35M	-46.33M	-441.44M	-669.44M	-656.90M	-510.89M	-407.01M	-64.18M	-95.21M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-28Sale

Owner: Ewald, Stephen P

Title: General Counsel & Corp. Secy.

Shares: 16,349

Price/Share: $450.00

Value: $7,357,050.00

Shares Owned: 20,343

Relationship: Officer

Ownership: Direct

2026-03-17Sale

Owner: Geiger, Jesse J

Title: President

Shares: 31,707

Price/Share: $455.30

Value: $14,436,197.10

Shares Owned: 15,000

Relationship: Officer

Ownership: Direct

2025-12-03Sale

Owner: Troendle, August J.

Title: CEO

Shares: 668

Price/Share: $590.69

Value: $394,580.92

Shares Owned: 646,184

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2025-12-02Sale

Owner: Troendle, August J.

Title: CEO

Shares: 5,698

Price/Share: $590.47

Value: $3,364,498.06

Shares Owned: 646,852

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2025-11-28Sale

Owner: Troendle, August J.

Title: CEO

Shares: 15,151

Price/Share: $593.46

Value: $8,991,512.46

Shares Owned: 675,728

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-28	Ewald, Stephen P	Officer	General Counsel & Corp. Secy.	Direct	Sale	16,349	450.00	$7,357,050.00	20,343	4
2026-03-17	Geiger, Jesse J	Officer	President	Direct	Sale	31,707	455.30	$14,436,197.10	15,000	4
2025-12-03	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	668	590.69	$394,580.92	646,184	4
2025-12-02	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	5,698	590.47	$3,364,498.06	646,852	4
2025-11-28	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	15,151	593.46	$8,991,512.46	675,728	4
2025-11-25	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	42,392	615.52	$26,093,123.84	732,210	4
2025-11-24	Burwig, Susan E	Officer	Exec. VP, Operations	Direct	Sale	20,000	609.15	$12,183,000.00	27,500	4
2025-11-21	Brady, Kevin M.	Officer	CFO & Treasurer	Direct	Sale	3,000	590.35	$1,771,050.00	6,000	4
2025-11-21	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	21,858	592.18	$12,943,870.44	833,627	4
2025-11-19	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	23,862	592.07	$14,127,974.34	862,315	4
2025-11-17	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	6,047	591.00	$3,573,777.00	893,368	4
2025-11-14	Kraft, Robert O.	Director	-	Direct	Sale	6,472	591.85	$3,830,453.20	833	4
2025-11-13	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	5,128	601.37	$3,083,825.36	914,162	4
2025-11-11	Burwig, Susan E	Officer	Exec. VP, Operations	Direct	Sale	18,000	605.00	$10,890,000.00	47,500	4
2025-11-05	Geiger, Jesse J	Officer	President	Direct	Sale	21,503	595.66	$12,808,476.98	15,000	4
2025-10-30	Davenport, Fred B Jr	Director	-	Direct	Sale	5,972	581.88	$3,474,987.36	3,498	4
2025-10-29	Geiger, Jesse J	Officer	President	Direct	Sale	3,568	585.00	$2,087,280.00	36,503	4
2025-10-27	Burwig, Susan E	Officer	Exec. VP, Operations	Direct	Sale	2,000	605.01	$1,210,020.00	65,500	4
2025-10-27	Ewald, Stephen P	Officer	General Counsel & Corp. Secy.	Direct	Sale	15,230	598.85	$9,120,485.50	13,343	4
2025-09-03	Burwig, Susan E	Officer	Exec. VP, Operations	Direct	Sale	10,000	480.00	$4,800,000.00	57,500	4
2025-09-02	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	1,197	475.11	$568,706.67	924,602	4
2025-08-27	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	620	475.00	$294,500.00	961,995	4
2025-08-19	Mccarthy, Cornelius P. Ii…	Director	-	Direct	Sale	1,662	465.04	$772,896.48	10,197	4
2025-07-28	Burwig, Susan E	Officer	Exec. VP, Operations	Direct	Sale	7,500	450.14	$3,376,050.00	57,500	4
2025-07-28	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	48,487	451.69	$21,901,093.03	962,615	4
2025-07-28	Ewald, Stephen P	Officer	General Counsel & Corp. Secy.	Direct	Sale	3,000	450.00	$1,350,000.00	10,343	4
2025-07-24	Brady, Kevin M.	Officer	CFO & Treasurer	Direct	Sale	12,000	454.23	$5,450,760.00	6,000	4
2025-07-24	Geiger, Jesse J	Officer	President	Direct	Sale	41,801	453.11	$18,940,451.11	36,503	4
2025-04-24	Davenport, Fred B Jr	Director	-	Direct	Sale	1,712	301.82	$516,715.84	2,998	4
2025-02-27	Ewald, Stephen P	Officer	General Counsel & Corp. Secy.	Direct	Purchase	2	326.11	$652.22	13,343	4
2025-02-24	Carley, Brian T	Director	-	Direct	Sale	4,003	345.59	$1,383,396.77	26,032	4
2024-08-23	Kraft, Robert O.	Director	-	Direct	Sale	3,774	390.73	$1,474,615.02	520	4
2024-06-05	Burwig, Susan E	Officer	Exec. VP, Operations	Direct	Sale	7,681	401.20	$3,081,617.20	7,500	4
2024-05-28	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	5,695	395.49	$2,252,315.55	654,656	4
2024-05-22	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	55	400.00	$22,000.00	664,338	4
2024-05-20	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	4,020	400.19	$1,608,763.80	664,393	4
2024-05-16	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	7,060	403.09	$2,845,815.40	668,413	4
2024-05-10	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	4,956	402.89	$1,996,722.84	707,755	4
2024-05-09	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	3,486	400.17	$1,394,992.62	712,711	4
2024-05-07	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	28,032	404.48	$11,338,383.36	720,979	4
2024-05-02	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	3,396	400.44	$1,359,894.24	773,383	4
2024-04-29	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Direct	Sale	15,102	400.69	$6,051,220.38	791,541	4
2024-03-15	Burwig, Susan E	Officer	Exec. VP, Operations	Direct	Sale	102	403.00	$41,106.00	15,181	4
2024-03-14	Keating, Ashley M.	Director	-	Direct	Sale	250	409.87	$102,467.50	250	4
2024-03-08	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	25,000	408.71	$10,217,750.00	4,733,019	4
2024-03-07	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	75,000	410.74	$30,805,500.00	4,758,019	4
2024-03-07	Keating, Ashley M.	Director	-	Direct	Sale	472	415.00	$195,880.00	0	4
2024-03-05	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	50,000	402.70	$20,135,000.00	4,933,019	4
2024-03-05	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	50,000	402.70	$20,135,000.00	4,933,019	4
2024-03-04	Geiger, Jesse J	Officer	President	Direct	Sale	22,321	403.03	$8,996,032.63	3,824	4
2024-03-01	Ewald, Stephen P	Officer	General Counsel & Corp. Secy.	Direct	Sale	350	400.79	$140,276.50	13,341	4
2024-03-01	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	80,000	401.88	$32,150,400.00	5,033,019	4
2024-03-01	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	80,000	401.88	$32,150,400.00	5,033,019	4
2024-02-29	Geiger, Jesse J	Officer	President	Direct	Sale	2,558	393.51	$1,006,598.58	3,824	4
2024-02-28	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	50,000	404.13	$20,206,500.00	5,133,019	4
2024-02-28	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	50,000	404.13	$20,206,500.00	5,133,019	4
2024-02-28	Keating, Ashley M.	Director	-	Direct	Sale	500	405.00	$202,500.00	0	4
2024-02-26	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	56,928	402.38	$22,906,688.64	5,233,019	4
2024-02-26	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	56,928	402.38	$22,906,688.64	5,233,019	4
2024-02-26	Keating, Ashley M.	Director	-	Direct	Sale	500	404.28	$202,140.00	0	4
2024-02-22	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	100,000	395.98	$39,598,000.00	5,389,947	4
2024-02-21	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	36,012	383.44	$13,808,441.28	5,489,947	4
2024-02-20	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	13,988	386.39	$5,404,823.32	5,525,959	4
2024-02-20	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	13,988	386.39	$5,404,823.32	5,525,959	4
2023-12-15	Burwig, Susan E	Officer	Exec. VP, Operations	Direct	Sale	2,009	303.00	$608,727.00	15,283	4
2023-12-01	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	24,039	273.26	$6,568,897.14	5,589,947	4
2023-11-29	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	21,257	272.74	$5,797,634.18	5,621,857	4
2023-11-28	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	21,833	273.66	$5,974,818.78	5,643,114	4
2023-11-28	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	21,833	273.66	$5,974,818.78	5,643,114	4
2023-11-22	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	25,000	277.81	$6,945,250.00	5,689,947	4
2023-11-22	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	25,000	277.81	$6,945,250.00	5,689,947	4
2023-11-21	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	25,000	277.37	$6,934,250.00	5,714,947	4
2023-11-21	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	25,000	277.37	$6,934,250.00	5,714,947	4
2023-11-20	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	50,000	275.45	$13,772,500.00	5,739,947	4
2023-11-20	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	50,000	275.45	$13,772,500.00	5,739,947	4
2023-11-16	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	17,000	281.61	$4,787,370.00	5,839,947	4
2023-11-16	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	17,000	281.61	$4,787,370.00	5,839,947	4
2023-09-21	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	61,655	244.27	$15,060,466.85	5,914,947	4
2023-09-21	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	61,655	244.27	$15,060,466.85	5,914,947	4
2023-09-19	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	137,379	259.66	$35,671,831.14	6,042,255	4
2023-09-19	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	137,379	259.66	$35,671,831.14	6,042,255	4
2023-08-14	Kraft, Robert O.	Director	-	Direct	Sale	13,782	265.67	$3,661,463.94	188	4
2023-07-31	Brady, Kevin M.	Officer	CFO & Treasurer	Direct	Sale	7,000	255.00	$1,785,000.00	6,000	4
2023-07-27	Ewald, Stephen P	Officer	General Counsel & Corp. Secy.	Direct	Sale	21,850	254.39	$5,558,421.50	14,854	4
2023-06-08	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	49,347	220.85	$10,898,284.95	6,233,019	4
2023-06-08	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	49,347	220.85	$10,898,284.95	6,233,019	4
2023-06-07	Medpace, Investors, Llc	TenPercentOwner	-	Direct	Sale	110,324	223.05	$24,607,768.20	6,282,366	4
2023-06-07	Troendle, August J.	Director,Officer,TenPercentOwner	CEO	Indirect	Sale	110,324	223.05	$24,607,768.20	6,282,366	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

78.58%

Inst. Shares: 22,350,982

Shares Outstanding: 28,445,000

2025-12-31

76.85%

Inst. Shares: 22,168,162

Shares Outstanding: 28,846,000

2025-09-30

80.48%

Inst. Shares: 22,642,736

Shares Outstanding: 28,136,000

2025-06-30

86.53%

Inst. Shares: 24,749,038

Shares Outstanding: 28,601,000

2025-03-31

78.00%

Inst. Shares: 23,701,662

Shares Outstanding: 30,387,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	22,350,982	28,445,000	78.58%
2025-12-31	22,168,162	28,846,000	76.85%
2025-09-30	22,642,736	28,136,000	80.48%
2025-06-30	24,749,038	28,601,000	86.53%
2025-03-31	23,701,662	30,387,000	78.00%
2024-12-31	23,528,111	30,957,000	76.00%
2024-09-30	23,379,544	31,047,000	75.30%
2024-06-30	23,340,797	30,990,000	75.32%
2024-03-31	22,796,072	30,843,000	73.91%
2023-12-31	22,164,278	30,722,000	72.14%
2023-09-30	21,055,178	30,629,000	68.74%
2023-06-30	21,535,199	30,537,000	70.52%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Medpace Holdings, Inc. (MEDP) — SEC Financial Statements & Analysis

Medpace Holdings, Inc. (MEDP) is a services-commercial physical & biological research company, incorporated in DE. Medpace Holdings, Inc. trades on MEDP: Nasdaq as: MEDP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Medpace Holdings, Inc. reported a 24.67% year-over-year revenue growth, a Debt-to-Equity ratio of 3.74x, a Price-to-Sales (P/S) ratio of 5.36x (TTM), a Price-to-Book (P/B) ratio of 34.39 (TTM), at a market cap of $14.92B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 24.67%
Debt To Equity: 3.74x
P/S TTM: 5.36x
P/B TTM: 34.39
Market Cap: $14.92B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Medpace Holdings, Inc. in?

Medpace Holdings, Inc. (MEDP) operates in the Services-Commercial Physical & Biological Research industry.

What is MEDP's market cap?

Medpace Holdings, Inc. (MEDP) has a market capitalization of $14.92B as of 2026-06-30.

What is MEDP's P/E ratio?

Medpace Holdings, Inc. (MEDP)'s trailing twelve month P/E ratio is 30.36x as of 2026-06-30.

What exchange does MEDP trade on?

Medpace Holdings, Inc. (MEDP) trades on the MEDP: Nasdaq.

Where is Medpace Holdings, Inc. incorporated?

Medpace Holdings, Inc. is incorporated in DE.

Medpace Holdings, Inc. (MEDP) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.